| PERIOD ENDING | 3-Apr-09 | 28-Mar-08 | 31-Mar-07 | | Total Revenue | 6,149,854 | 5,874,419 | 5,199,366 | | Cost of Revenue | 1,226,927 | 1,220,330 | 1,215,826 | | | Gross Profit | 4,922,927 | 4,654,089 | 3,983,540 | | | Operating Expenses | | Research Development | 879,702 | 895,242 | 866,882 | | Selling General and Administrative | 2,728,792 | 2,762,906 | 2,325,178 | | Non Recurring | 7,550,882 | 168,530 | 70,236 | | Others | 233,461 | 225,131 | 201,502 | | | | Total Operating Expenses | 11,392,837 | 4,051,809 | 3,463,798 | | | | Operating Income or Loss | (6,469,910) | 602,280 | 519,742 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 45,437 | 139,723 | 139,113 | | Earnings Before Interest And Taxes | (6,424,473) | 742,003 | 658,855 | | Interest Expense | 29,705 | 29,480 | 27,233 | | Income Before Tax | (6,454,178) | 712,523 | 631,622 | | Income Tax Expense | 221,630 | 248,673 | 227,242 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,728,870) | 463,850 | 404,380 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,728,870) | 463,850 | 404,380 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,728,870) | $463,850 | $404,380 |
|
0.44% Nasdaq 
Income Statement
